Edwards Lifesciences Corp (EW)
70.38
+0.84
(+1.21%)
USD |
NYSE |
Nov 21, 16:00
70.39
+0.01
(+0.01%)
Pre-Market: 20:00
Edwards Lifesciences Enterprise Value: 37.73B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 37.73B |
| November 20, 2024 | 37.23B |
| November 19, 2024 | 37.62B |
| November 18, 2024 | 37.44B |
| November 15, 2024 | 36.18B |
| November 14, 2024 | 35.24B |
| November 13, 2024 | 35.45B |
| November 12, 2024 | 35.03B |
| November 11, 2024 | 35.56B |
| November 08, 2024 | 35.28B |
| November 07, 2024 | 35.05B |
| November 06, 2024 | 35.00B |
| November 05, 2024 | 35.55B |
| November 04, 2024 | 35.42B |
| November 01, 2024 | 36.05B |
| October 31, 2024 | 35.74B |
| October 30, 2024 | 36.70B |
| October 29, 2024 | 37.13B |
| October 28, 2024 | 36.63B |
| October 25, 2024 | 37.14B |
| October 24, 2024 | 37.71B |
| October 23, 2024 | 37.86B |
| October 22, 2024 | 37.05B |
| October 21, 2024 | 37.53B |
| October 18, 2024 | 37.66B |
| Date | Value |
|---|---|
| October 17, 2024 | 36.60B |
| October 16, 2024 | 36.50B |
| October 15, 2024 | 36.85B |
| October 14, 2024 | 37.28B |
| October 11, 2024 | 36.40B |
| October 10, 2024 | 36.48B |
| October 09, 2024 | 36.34B |
| October 08, 2024 | 36.64B |
| October 07, 2024 | 34.28B |
| October 04, 2024 | 34.84B |
| October 03, 2024 | 34.77B |
| October 02, 2024 | 34.64B |
| October 01, 2024 | 34.61B |
| September 30, 2024 | 35.14B |
| September 27, 2024 | 38.78B |
| September 26, 2024 | 38.29B |
| September 25, 2024 | 38.08B |
| September 24, 2024 | 38.63B |
| September 23, 2024 | 39.25B |
| September 20, 2024 | 38.93B |
| September 19, 2024 | 39.19B |
| September 18, 2024 | 39.35B |
| September 17, 2024 | 39.17B |
| September 16, 2024 | 40.46B |
| September 13, 2024 | 39.95B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
31.68B
Minimum
Mar 23 2020
80.39B
Maximum
Dec 30 2021
52.52B
Average
51.05B
Median
Sep 29 2022
Enterprise Value Benchmarks
| Teleflex Inc | 10.37B |
| Becton Dickinson & Co | 83.11B |
| NeuroOne Medical Technologies Corp | 19.94M |
| SINTX Technologies Inc | 1.094M |
| Nutriband Inc | 48.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.071B |
| Revenue (Quarterly) | 1.354B |
| Total Expenses (Quarterly) | 960.10M |
| EPS Diluted (Quarterly) | 5.13 |
| Gross Profit Margin (Quarterly) | 80.59% |
| Earnings Yield | 9.85% |
| Operating Earnings Yield | 4.26% |
| Normalized Earnings Yield | 3.672 |